These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33219422)
1. Placebo response in degenerative cerebellar ataxias: a descriptive review of randomized, placebo-controlled trials. Choi JH; Shin C; Kim HJ; Jeon B J Neurol; 2022 Jan; 269(1):62-71. PubMed ID: 33219422 [TBL] [Abstract][Full Text] [Related]
2. Nocebo in cerebellar ataxia: A systematic review and meta-analysis of placebo-controlled clinical trials. Alam JM; Hadjivassiliou M; Zis P J Neurol Sci; 2019 Jun; 401():112-117. PubMed ID: 31075682 [TBL] [Abstract][Full Text] [Related]
3. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial. Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987 [TBL] [Abstract][Full Text] [Related]
4. Antioxidants and other pharmacological treatments for Friedreich ataxia. Kearney M; Orrell RW; Fahey M; Pandolfo M Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953 [TBL] [Abstract][Full Text] [Related]
5. Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials. Saute JA; Donis KC; Serrano-Munuera C; Genis D; Ramirez LT; Mazzetti P; Pérez LV; Latorre P; Sequeiros J; Matilla-Dueñas A; Jardim LB; Cerebellum; 2012 Jun; 11(2):488-504. PubMed ID: 21964941 [TBL] [Abstract][Full Text] [Related]
6. Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials. Nishizawa M; Onodera O; Hirakawa A; Shimizu Y; Yamada M; J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):254-262. PubMed ID: 31937586 [TBL] [Abstract][Full Text] [Related]
7. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Romano S; Coarelli G; Marcotulli C; Leonardi L; Piccolo F; Spadaro M; Frontali M; Ferraldeschi M; Vulpiani MC; Ponzelli F; Salvetti M; Orzi F; Petrucci A; Vanacore N; Casali C; Ristori G Lancet Neurol; 2015 Oct; 14(10):985-91. PubMed ID: 26321318 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Misestimation in Patients with Degenerative Ataxia: Lessons from a Randomized Controlled Trial. Maas RPPWM; van de Warrenburg BPC Mov Disord; 2023 Jan; 38(1):133-137. PubMed ID: 36259428 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis. Bhartiya M; Kumar A; Singh RK; Radhakrishnan DM; Rajan R; Srivastava AK Cerebellum; 2023 Jun; 22(3):363-369. PubMed ID: 35451803 [TBL] [Abstract][Full Text] [Related]
10. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908 [TBL] [Abstract][Full Text] [Related]
11. Preparing for Disease-Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose? Maas RPPWM Mov Disord; 2023 Jun; 38(6):917-923. PubMed ID: 37475615 [No Abstract] [Full Text] [Related]
12. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. Sorbi S; Forleo P; Fani C; Piacentini S Clin Neuropharmacol; 2000; 23(2):114-8. PubMed ID: 10803803 [TBL] [Abstract][Full Text] [Related]
13. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus. Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380 [TBL] [Abstract][Full Text] [Related]
14. The neurological update: therapies for cerebellar ataxias in 2020. Gandini J; Manto M; Bremova-Ertl T; Feil K; Strupp M J Neurol; 2020 Apr; 267(4):1211-1220. PubMed ID: 32002650 [TBL] [Abstract][Full Text] [Related]